Moreover, they found no significant difference in IDO1 expression on inflammatory cells between HBV+HCC and HBV−HCC, considered to be a result of the small number of HBV−HCC patients included in their study.166. This evidence concerns the gene IDO1 and hepatocellular carcinoma.